Birmingham Firm Calls AI Cancer Testing a ‘Pivotal Moment’ for Early Detection
A Birmingham life sciences company has described the Government’s renewed focus on genetics and early diagnosis in its National Cancer Plan as a “pivotal moment” in the fight against cancer. Jeff Bousfield, CEO of Quinton-based Nonacus, said the plan’s commitment to expanding access to genetic testing could significantly improve survival rates and patient outcomes across […]